nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RXRA—systemic lupus erythematosus	0.561	1	CbGaD
Alitretinoin—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0245	0.203	CbGbCtD
Alitretinoin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0175	0.144	CbGbCtD
Alitretinoin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0132	0.109	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—systemic lupus erythematosus	0.0114	0.0939	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—systemic lupus erythematosus	0.0112	0.0927	CbGbCtD
Alitretinoin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0106	0.0878	CbGbCtD
Alitretinoin—ABCB1—Prednisone—systemic lupus erythematosus	0.0106	0.0875	CbGbCtD
Alitretinoin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.01	0.083	CbGbCtD
Alitretinoin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00661	0.0546	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—systemic lupus erythematosus	0.00531	0.0439	CbGbCtD
Alitretinoin—CRABP1—connective tissue—systemic lupus erythematosus	0.00208	0.046	CbGeAlD
Alitretinoin—Isotretinoin—RXRA—systemic lupus erythematosus	0.00204	0.395	CrCbGaD
Alitretinoin—CRABP2—connective tissue—systemic lupus erythematosus	0.00188	0.0416	CbGeAlD
Alitretinoin—CRABP1—skin of body—systemic lupus erythematosus	0.00188	0.0416	CbGeAlD
Alitretinoin—Acitretin—RXRA—systemic lupus erythematosus	0.00174	0.336	CrCbGaD
Alitretinoin—CRABP1—cortex of kidney—systemic lupus erythematosus	0.00172	0.0382	CbGeAlD
Alitretinoin—CYP1A2—urine—systemic lupus erythematosus	0.00172	0.0381	CbGeAlD
Alitretinoin—CRABP2—skin of body—systemic lupus erythematosus	0.0017	0.0376	CbGeAlD
Alitretinoin—RXRA—kidney—systemic lupus erythematosus	0.00159	0.0353	CbGeAlD
Alitretinoin—CRABP1—tendon—systemic lupus erythematosus	0.00143	0.0316	CbGeAlD
Alitretinoin—CRABP2—tendon—systemic lupus erythematosus	0.00129	0.0286	CbGeAlD
Alitretinoin—RARG—skin of body—systemic lupus erythematosus	0.00124	0.0274	CbGeAlD
Alitretinoin—Tretinoin—RXRA—systemic lupus erythematosus	0.00117	0.227	CrCbGaD
Alitretinoin—CRABP1—nervous system—systemic lupus erythematosus	0.00116	0.0257	CbGeAlD
Alitretinoin—RARB—tendon—systemic lupus erythematosus	0.00115	0.0256	CbGeAlD
Alitretinoin—CRABP2—lung—systemic lupus erythematosus	0.00113	0.0251	CbGeAlD
Alitretinoin—RXRG—tendon—systemic lupus erythematosus	0.00113	0.025	CbGeAlD
Alitretinoin—CRABP1—central nervous system—systemic lupus erythematosus	0.00112	0.0248	CbGeAlD
Alitretinoin—RARA—kidney—systemic lupus erythematosus	0.0011	0.0243	CbGeAlD
Alitretinoin—RXRB—tendon—systemic lupus erythematosus	0.00106	0.0235	CbGeAlD
Alitretinoin—CRABP2—nervous system—systemic lupus erythematosus	0.00105	0.0233	CbGeAlD
Alitretinoin—RXRA—nervous system—systemic lupus erythematosus	0.00104	0.0232	CbGeAlD
Alitretinoin—RARB—lung—systemic lupus erythematosus	0.00101	0.0225	CbGeAlD
Alitretinoin—CRABP2—central nervous system—systemic lupus erythematosus	0.00101	0.0224	CbGeAlD
Alitretinoin—RXRA—central nervous system—systemic lupus erythematosus	0.00101	0.0223	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—systemic lupus erythematosus	0.000942	0.0209	CbGeAlD
Alitretinoin—RARG—tendon—systemic lupus erythematosus	0.000942	0.0209	CbGeAlD
Alitretinoin—RXRB—lung—systemic lupus erythematosus	0.000931	0.0206	CbGeAlD
Alitretinoin—RXRG—nervous system—systemic lupus erythematosus	0.000917	0.0203	CbGeAlD
Alitretinoin—CYP1A2—blood plasma—systemic lupus erythematosus	0.000897	0.0199	CbGeAlD
Alitretinoin—RARA—tendon—systemic lupus erythematosus	0.000886	0.0196	CbGeAlD
Alitretinoin—RXRG—central nervous system—systemic lupus erythematosus	0.000883	0.0196	CbGeAlD
Alitretinoin—RXRB—nervous system—systemic lupus erythematosus	0.000862	0.0191	CbGeAlD
Alitretinoin—RARA—bone marrow—systemic lupus erythematosus	0.000858	0.019	CbGeAlD
Alitretinoin—RXRB—central nervous system—systemic lupus erythematosus	0.00083	0.0184	CbGeAlD
Alitretinoin—RARG—lung—systemic lupus erythematosus	0.000827	0.0183	CbGeAlD
Alitretinoin—RARA—lung—systemic lupus erythematosus	0.000777	0.0172	CbGeAlD
Alitretinoin—RARG—nervous system—systemic lupus erythematosus	0.000765	0.017	CbGeAlD
Alitretinoin—RARG—central nervous system—systemic lupus erythematosus	0.000737	0.0163	CbGeAlD
Alitretinoin—RARA—nervous system—systemic lupus erythematosus	0.00072	0.016	CbGeAlD
Alitretinoin—RARA—central nervous system—systemic lupus erythematosus	0.000693	0.0154	CbGeAlD
Alitretinoin—ABCB1—blood plasma—systemic lupus erythematosus	0.00046	0.0102	CbGeAlD
Alitretinoin—CYP1A2—lung—systemic lupus erythematosus	0.000288	0.00639	CbGeAlD
Alitretinoin—ABCB1—nephron tubule—systemic lupus erythematosus	0.000237	0.00525	CbGeAlD
Alitretinoin—Acitretin—ALB—systemic lupus erythematosus	0.000221	0.0427	CrCbGaD
Alitretinoin—ABCB1—kidney—systemic lupus erythematosus	0.000208	0.00462	CbGeAlD
Alitretinoin—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000203	0.0045	CbGeAlD
Alitretinoin—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000179	0.00397	CbGeAlD
Alitretinoin—ABCB1—bone marrow—systemic lupus erythematosus	0.000163	0.00361	CbGeAlD
Alitretinoin—ABCB1—lung—systemic lupus erythematosus	0.000148	0.00327	CbGeAlD
Alitretinoin—ABCB1—nervous system—systemic lupus erythematosus	0.000137	0.00303	CbGeAlD
Alitretinoin—ABCB1—central nervous system—systemic lupus erythematosus	0.000132	0.00292	CbGeAlD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	8.39e-05	0.000974	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	8.37e-05	0.000971	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CDKN1A—systemic lupus erythematosus	8.36e-05	0.00097	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—TNFSF13—systemic lupus erythematosus	8.26e-05	0.000959	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—EP300—systemic lupus erythematosus	8.25e-05	0.000958	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—NR3C1—systemic lupus erythematosus	8.18e-05	0.00095	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	8.18e-05	0.000949	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NAT2—systemic lupus erythematosus	8.09e-05	0.000938	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NAT2—systemic lupus erythematosus	8.09e-05	0.000938	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	8.03e-05	0.000931	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	8.03e-05	0.000931	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	8.02e-05	0.000931	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SNRPB—systemic lupus erythematosus	8e-05	0.000928	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—FAS—systemic lupus erythematosus	7.93e-05	0.00092	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	7.81e-05	0.000906	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	7.75e-05	0.000899	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—TNFSF13—systemic lupus erythematosus	7.56e-05	0.000877	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	7.48e-05	0.000868	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—TNFSF13—systemic lupus erythematosus	7.41e-05	0.00086	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	7.41e-05	0.00086	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.41e-05	0.000859	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—systemic lupus erythematosus	7.36e-05	0.000854	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	7.34e-05	0.000851	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	7.34e-05	0.000851	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SNRPB—systemic lupus erythematosus	7.32e-05	0.000849	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—PPARG—systemic lupus erythematosus	7.25e-05	0.000841	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	7.2e-05	0.000835	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SNRPB—systemic lupus erythematosus	7.18e-05	0.000833	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—TNFSF13—systemic lupus erythematosus	7.11e-05	0.000824	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—TNFSF13—systemic lupus erythematosus	7.11e-05	0.000824	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	7.09e-05	0.000823	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	7.03e-05	0.000816	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	7.03e-05	0.000816	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	7.03e-05	0.000816	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	6.95e-05	0.000806	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	6.95e-05	0.000806	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TGFB1—systemic lupus erythematosus	6.92e-05	0.000803	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SNRPB—systemic lupus erythematosus	6.88e-05	0.000798	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SNRPB—systemic lupus erythematosus	6.88e-05	0.000798	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—systemic lupus erythematosus	6.87e-05	0.000797	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	6.87e-05	0.000797	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	6.78e-05	0.000786	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	6.77e-05	0.000786	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	6.67e-05	0.000774	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	6.66e-05	0.000773	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—VDR—systemic lupus erythematosus	6.65e-05	0.000771	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—systemic lupus erythematosus	6.46e-05	0.000749	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.43e-05	0.000746	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.43e-05	0.000746	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	6.43e-05	0.000745	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.41e-05	0.000744	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—VDR—systemic lupus erythematosus	6.37e-05	0.000739	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	6.37e-05	0.000739	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—PPARG—systemic lupus erythematosus	6.34e-05	0.000735	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	6.31e-05	0.000732	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.15e-05	0.000713	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.1e-05	0.000708	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	6.1e-05	0.000708	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SNRPD1—systemic lupus erythematosus	6.06e-05	0.000703	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	6.04e-05	0.000701	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	5.98e-05	0.000694	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	5.96e-05	0.000692	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.95e-05	0.00069	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.91e-05	0.000686	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.88e-05	0.000682	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	5.85e-05	0.000679	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	5.83e-05	0.000676	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.78e-05	0.000671	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.78e-05	0.000671	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.78e-05	0.00067	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.76e-05	0.000669	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	5.73e-05	0.000665	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	5.73e-05	0.000665	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	5.58e-05	0.000647	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—systemic lupus erythematosus	5.54e-05	0.000643	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.54e-05	0.000643	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.53e-05	0.000641	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.53e-05	0.000641	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MTA2—systemic lupus erythematosus	5.48e-05	0.000636	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	5.48e-05	0.000636	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.3e-05	0.000615	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	5.27e-05	0.000611	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	5.27e-05	0.000611	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—systemic lupus erythematosus	5.21e-05	0.000605	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.17e-05	0.000599	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	5.12e-05	0.000594	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	5.12e-05	0.000594	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.09e-05	0.00059	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.06e-05	0.000587	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.06e-05	0.000587	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LYN—systemic lupus erythematosus	4.98e-05	0.000578	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.95e-05	0.000575	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	4.9e-05	0.000568	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	4.89e-05	0.000567	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.82e-05	0.000559	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.75e-05	0.000551	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—EP300—systemic lupus erythematosus	4.74e-05	0.00055	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.72e-05	0.000548	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	4.72e-05	0.000548	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	4.69e-05	0.000544	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	4.65e-05	0.00054	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	4.64e-05	0.000538	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.63e-05	0.000537	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	4.6e-05	0.000534	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	4.57e-05	0.00053	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—RXRA—systemic lupus erythematosus	4.53e-05	0.000526	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—RXRA—systemic lupus erythematosus	4.53e-05	0.000526	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.5e-05	0.000523	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—JUNB—systemic lupus erythematosus	4.49e-05	0.000521	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.44e-05	0.000515	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.44e-05	0.000515	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—CDKN1A—systemic lupus erythematosus	4.36e-05	0.000506	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PTPRC—systemic lupus erythematosus	4.27e-05	0.000495	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	4.24e-05	0.000492	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.21e-05	0.000488	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.21e-05	0.000488	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	4.18e-05	0.000485	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.12e-05	0.000478	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—JUNB—systemic lupus erythematosus	4.11e-05	0.000477	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—JUNB—systemic lupus erythematosus	4.03e-05	0.000468	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ADIPOQ—systemic lupus erythematosus	4.03e-05	0.000467	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—RXRA—systemic lupus erythematosus	3.94e-05	0.000457	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	3.92e-05	0.000454	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.000213	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—JUNB—systemic lupus erythematosus	3.86e-05	0.000448	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—JUNB—systemic lupus erythematosus	3.86e-05	0.000448	CbGpPWpGaD
Alitretinoin—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000213	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—systemic lupus erythematosus	3.85e-05	0.000212	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000212	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	3.84e-05	0.000212	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	3.84e-05	0.000211	CcSEcCtD
Alitretinoin—Pain—Hydrocortisone—systemic lupus erythematosus	3.83e-05	0.000211	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.000211	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.000211	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—systemic lupus erythematosus	3.83e-05	0.000211	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	3.83e-05	0.000211	CcSEcCtD
Alitretinoin—Insomnia—Triamcinolone—systemic lupus erythematosus	3.82e-05	0.00021	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	3.81e-05	0.000442	CbGpPWpGaD
Alitretinoin—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.81e-05	0.00021	CcSEcCtD
Alitretinoin—Infection—Betamethasone—systemic lupus erythematosus	3.8e-05	0.000209	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—systemic lupus erythematosus	3.8e-05	0.000209	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.79e-05	0.000209	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	3.79e-05	0.000209	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.78e-05	0.000208	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	3.78e-05	0.000208	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—systemic lupus erythematosus	3.78e-05	0.000208	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—systemic lupus erythematosus	3.78e-05	0.000208	CcSEcCtD
Alitretinoin—Shock—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000207	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000207	CcSEcCtD
Alitretinoin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.76e-05	0.000207	CcSEcCtD
Alitretinoin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.75e-05	0.000207	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.75e-05	0.000207	CcSEcCtD
Alitretinoin—Agitation—Prednisone—systemic lupus erythematosus	3.75e-05	0.000207	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.75e-05	0.000206	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.75e-05	0.000206	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000206	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000206	CcSEcCtD
Alitretinoin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.71e-05	0.000204	CcSEcCtD
Alitretinoin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.71e-05	0.000204	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000204	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.71e-05	0.000204	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—TNFSF13—systemic lupus erythematosus	3.7e-05	0.00043	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.7e-05	0.000204	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.7e-05	0.000204	CcSEcCtD
Alitretinoin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.69e-05	0.000203	CcSEcCtD
Alitretinoin—Malaise—Prednisone—systemic lupus erythematosus	3.68e-05	0.000203	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	3.67e-05	0.000425	CbGpPWpGaD
Alitretinoin—Eye disorder—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000202	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.66e-05	0.000202	CcSEcCtD
Alitretinoin—Syncope—Prednisone—systemic lupus erythematosus	3.66e-05	0.000202	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000201	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	3.65e-05	0.000424	CbGpPWpGaD
Alitretinoin—Anorexia—Dexamethasone—systemic lupus erythematosus	3.65e-05	0.000201	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—systemic lupus erythematosus	3.65e-05	0.000201	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—systemic lupus erythematosus	3.64e-05	0.000201	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.0002	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.0002	CcSEcCtD
Alitretinoin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.62e-05	0.000199	CcSEcCtD
Alitretinoin—Asthenia—Cyclosporine—systemic lupus erythematosus	3.62e-05	0.000199	CcSEcCtD
Alitretinoin—Pain—Triamcinolone—systemic lupus erythematosus	3.61e-05	0.000199	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—systemic lupus erythematosus	3.61e-05	0.000418	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RXRA—systemic lupus erythematosus	3.6e-05	0.000418	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.59e-05	0.000198	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—SNRPB—systemic lupus erythematosus	3.59e-05	0.000416	CbGpPWpGaD
Alitretinoin—Hypotension—Dexamethasone—systemic lupus erythematosus	3.58e-05	0.000197	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—systemic lupus erythematosus	3.58e-05	0.000197	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.57e-05	0.000414	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—VDR—systemic lupus erythematosus	3.57e-05	0.000414	CbGpPWpGaD
Alitretinoin—Pruritus—Cyclosporine—systemic lupus erythematosus	3.57e-05	0.000196	CcSEcCtD
Alitretinoin—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.56e-05	0.000196	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000196	CcSEcCtD
Alitretinoin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000195	CcSEcCtD
Alitretinoin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000195	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—systemic lupus erythematosus	3.54e-05	0.000195	CcSEcCtD
Alitretinoin—RARB—Gene Expression—RXRA—systemic lupus erythematosus	3.53e-05	0.00041	CbGpPWpGaD
Alitretinoin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.53e-05	0.000194	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—systemic lupus erythematosus	3.53e-05	0.000194	CcSEcCtD
Alitretinoin—Chills—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000194	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.49e-05	0.000192	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.49e-05	0.000192	CcSEcCtD
Alitretinoin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.48e-05	0.000192	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—systemic lupus erythematosus	3.48e-05	0.000191	CcSEcCtD
Alitretinoin—Myalgia—Prednisone—systemic lupus erythematosus	3.48e-05	0.000191	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.48e-05	0.000191	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	3.47e-05	0.000403	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.47e-05	0.000191	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—systemic lupus erythematosus	3.47e-05	0.000191	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—systemic lupus erythematosus	3.47e-05	0.000191	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—systemic lupus erythematosus	3.46e-05	0.000191	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—systemic lupus erythematosus	3.46e-05	0.000191	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.46e-05	0.000401	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.46e-05	0.000401	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.45e-05	0.00019	CcSEcCtD
Alitretinoin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.45e-05	0.00019	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.44e-05	0.000189	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.44e-05	0.000189	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.44e-05	0.000189	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—systemic lupus erythematosus	3.44e-05	0.000189	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000189	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.42e-05	0.000396	CbGpPWpGaD
Alitretinoin—Malnutrition—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000188	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000188	CcSEcCtD
Alitretinoin—RARA—Gene Expression—RXRA—systemic lupus erythematosus	3.39e-05	0.000393	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RXRA—systemic lupus erythematosus	3.39e-05	0.000393	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.39e-05	0.000393	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.38e-05	0.000186	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.37e-05	0.000185	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.37e-05	0.000185	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TNF—systemic lupus erythematosus	3.37e-05	0.000391	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.37e-05	0.00039	CbGpPWpGaD
Alitretinoin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.36e-05	0.000185	CcSEcCtD
Alitretinoin—Urticaria—Triamcinolone—systemic lupus erythematosus	3.35e-05	0.000184	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.34e-05	0.000184	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.34e-05	0.000184	CcSEcCtD
Alitretinoin—Dizziness—Cyclosporine—systemic lupus erythematosus	3.33e-05	0.000184	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.33e-05	0.000184	CcSEcCtD
Alitretinoin—Oedema—Prednisone—systemic lupus erythematosus	3.33e-05	0.000184	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.33e-05	0.000183	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.33e-05	0.000183	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.33e-05	0.000183	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	3.32e-05	0.000385	CbGpPWpGaD
Alitretinoin—Infection—Prednisone—systemic lupus erythematosus	3.31e-05	0.000182	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000182	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.29e-05	0.000381	CbGpPWpGaD
Alitretinoin—Shock—Prednisone—systemic lupus erythematosus	3.28e-05	0.000181	CcSEcCtD
Alitretinoin—Pain—Betamethasone—systemic lupus erythematosus	3.27e-05	0.00018	CcSEcCtD
Alitretinoin—Pain—Dexamethasone—systemic lupus erythematosus	3.27e-05	0.00018	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.27e-05	0.00018	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—VDR—systemic lupus erythematosus	3.26e-05	0.000378	CbGpPWpGaD
Alitretinoin—Tachycardia—Prednisone—systemic lupus erythematosus	3.25e-05	0.000179	CcSEcCtD
Alitretinoin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.25e-05	0.000179	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—systemic lupus erythematosus	3.24e-05	0.000178	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.22e-05	0.000177	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—systemic lupus erythematosus	3.22e-05	0.000177	CcSEcCtD
Alitretinoin—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.21e-05	0.000177	CcSEcCtD
Alitretinoin—RARG—Gene Expression—NR3C1—systemic lupus erythematosus	3.21e-05	0.000372	CbGpPWpGaD
Alitretinoin—Vomiting—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.000176	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.2e-05	0.000372	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—VDR—systemic lupus erythematosus	3.2e-05	0.000371	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	3.2e-05	0.000371	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.19e-05	0.00037	CbGpPWpGaD
Alitretinoin—Rash—Cyclosporine—systemic lupus erythematosus	3.18e-05	0.000175	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—systemic lupus erythematosus	3.18e-05	0.000175	CcSEcCtD
Alitretinoin—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.18e-05	0.000175	CcSEcCtD
Alitretinoin—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.17e-05	0.000174	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.17e-05	0.000174	CcSEcCtD
Alitretinoin—Headache—Cyclosporine—systemic lupus erythematosus	3.16e-05	0.000174	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000174	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.15e-05	0.000174	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.15e-05	0.000174	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.13e-05	0.000172	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.13e-05	0.000172	CcSEcCtD
Alitretinoin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000172	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.11e-05	0.000171	CcSEcCtD
Alitretinoin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.1e-05	0.000171	CcSEcCtD
Alitretinoin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.1e-05	0.000171	CcSEcCtD
Alitretinoin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.1e-05	0.000171	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	3.1e-05	0.000359	CbGpPWpGaD
Alitretinoin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.08e-05	0.00017	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000169	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—VDR—systemic lupus erythematosus	3.07e-05	0.000356	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—VDR—systemic lupus erythematosus	3.07e-05	0.000356	CbGpPWpGaD
Alitretinoin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.07e-05	0.000169	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.05e-05	0.000354	CbGpPWpGaD
Alitretinoin—Urticaria—Betamethasone—systemic lupus erythematosus	3.04e-05	0.000167	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—systemic lupus erythematosus	3.04e-05	0.000167	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3.04e-05	0.000352	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.04e-05	0.000352	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.04e-05	0.000167	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Asthenia—Triamcinolone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.03e-05	0.000167	CcSEcCtD
Alitretinoin—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.02e-05	0.000166	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—systemic lupus erythematosus	3.02e-05	0.000166	CcSEcCtD
Alitretinoin—Nausea—Cyclosporine—systemic lupus erythematosus	2.99e-05	0.000165	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—systemic lupus erythematosus	2.99e-05	0.000165	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.99e-05	0.000347	CbGpPWpGaD
Alitretinoin—Pruritus—Triamcinolone—systemic lupus erythematosus	2.98e-05	0.000164	CcSEcCtD
Alitretinoin—Cough—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000164	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.98e-05	0.000164	CcSEcCtD
Alitretinoin—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.96e-05	0.000163	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000163	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.95e-05	0.000342	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR3C1—systemic lupus erythematosus	2.94e-05	0.000341	CbGpPWpGaD
Alitretinoin—Dyspepsia—Prednisone—systemic lupus erythematosus	2.93e-05	0.000162	CcSEcCtD
Alitretinoin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.92e-05	0.000161	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—systemic lupus erythematosus	2.91e-05	0.00016	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—systemic lupus erythematosus	2.91e-05	0.00016	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—systemic lupus erythematosus	2.91e-05	0.00016	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—JAK1—systemic lupus erythematosus	2.9e-05	0.000337	CbGpPWpGaD
Alitretinoin—Decreased appetite—Prednisone—systemic lupus erythematosus	2.9e-05	0.00016	CcSEcCtD
Alitretinoin—Rash—Prednisolone—systemic lupus erythematosus	2.89e-05	0.000159	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—systemic lupus erythematosus	2.89e-05	0.000159	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.89e-05	0.000335	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.89e-05	0.000159	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.88e-05	0.000159	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NR3C1—systemic lupus erythematosus	2.88e-05	0.000334	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2.88e-05	0.000334	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.88e-05	0.000334	CbGpPWpGaD
Alitretinoin—Fatigue—Prednisone—systemic lupus erythematosus	2.87e-05	0.000158	CcSEcCtD
Alitretinoin—Headache—Prednisolone—systemic lupus erythematosus	2.87e-05	0.000158	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000158	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PPARG—systemic lupus erythematosus	2.86e-05	0.000332	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—systemic lupus erythematosus	2.86e-05	0.000332	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2.85e-05	0.000331	CbGpPWpGaD
Alitretinoin—Constipation—Prednisone—systemic lupus erythematosus	2.85e-05	0.000157	CcSEcCtD
Alitretinoin—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.000157	CcSEcCtD
Alitretinoin—Rash—Hydrocortisone—systemic lupus erythematosus	2.82e-05	0.000156	CcSEcCtD
Alitretinoin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.82e-05	0.000155	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000155	CcSEcCtD
Alitretinoin—Headache—Hydrocortisone—systemic lupus erythematosus	2.81e-05	0.000155	CcSEcCtD
Alitretinoin—Dizziness—Triamcinolone—systemic lupus erythematosus	2.79e-05	0.000154	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000153	CcSEcCtD
Alitretinoin—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.78e-05	0.000153	CcSEcCtD
Alitretinoin—Infection—Methotrexate—systemic lupus erythematosus	2.77e-05	0.000152	CcSEcCtD
Alitretinoin—RARA—Gene Expression—NR3C1—systemic lupus erythematosus	2.76e-05	0.00032	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR3C1—systemic lupus erythematosus	2.76e-05	0.00032	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	2.75e-05	0.000319	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.75e-05	0.000151	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—systemic lupus erythematosus	2.75e-05	0.000151	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—systemic lupus erythematosus	2.75e-05	0.000151	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—systemic lupus erythematosus	2.72e-05	0.00015	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—IL6—systemic lupus erythematosus	2.72e-05	0.000315	CbGpPWpGaD
Alitretinoin—Pruritus—Betamethasone—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	2.7e-05	0.000313	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—systemic lupus erythematosus	2.68e-05	0.000148	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000147	CcSEcCtD
Alitretinoin—Nausea—Hydrocortisone—systemic lupus erythematosus	2.66e-05	0.000146	CcSEcCtD
Alitretinoin—Rash—Triamcinolone—systemic lupus erythematosus	2.66e-05	0.000146	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.66e-05	0.000146	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000146	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—systemic lupus erythematosus	2.65e-05	0.000146	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.65e-05	0.000146	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.65e-05	0.000307	CbGpPWpGaD
Alitretinoin—Urticaria—Prednisone—systemic lupus erythematosus	2.65e-05	0.000146	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.64e-05	0.000306	CbGpPWpGaD
Alitretinoin—Headache—Methylprednisolone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.62e-05	0.000144	CcSEcCtD
Alitretinoin—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.62e-05	0.000144	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000143	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—ALB—systemic lupus erythematosus	2.57e-05	0.000299	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—systemic lupus erythematosus	2.57e-05	0.000299	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.56e-05	0.000297	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—systemic lupus erythematosus	2.53e-05	0.000139	CcSEcCtD
Alitretinoin—Dizziness—Betamethasone—systemic lupus erythematosus	2.53e-05	0.000139	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000139	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—systemic lupus erythematosus	2.51e-05	0.000138	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.5e-05	0.000138	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—systemic lupus erythematosus	2.5e-05	0.000138	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PPARG—systemic lupus erythematosus	2.49e-05	0.000288	CbGpPWpGaD
Alitretinoin—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000137	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000136	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.47e-05	0.000287	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.47e-05	0.000286	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.47e-05	0.000286	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—systemic lupus erythematosus	2.46e-05	0.000286	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—systemic lupus erythematosus	2.46e-05	0.000286	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.45e-05	0.000135	CcSEcCtD
Alitretinoin—RXRA—Metabolism—NAT2—systemic lupus erythematosus	2.45e-05	0.000284	CbGpPWpGaD
Alitretinoin—Vomiting—Dexamethasone—systemic lupus erythematosus	2.43e-05	0.000134	CcSEcCtD
Alitretinoin—Vomiting—Betamethasone—systemic lupus erythematosus	2.43e-05	0.000134	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.42e-05	0.000133	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.42e-05	0.00028	CbGpPWpGaD
Alitretinoin—Rash—Betamethasone—systemic lupus erythematosus	2.41e-05	0.000133	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—systemic lupus erythematosus	2.41e-05	0.000133	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.41e-05	0.000133	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—systemic lupus erythematosus	2.41e-05	0.000133	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000132	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000132	CcSEcCtD
Alitretinoin—Headache—Betamethasone—systemic lupus erythematosus	2.4e-05	0.000132	CcSEcCtD
Alitretinoin—Headache—Dexamethasone—systemic lupus erythematosus	2.4e-05	0.000132	CcSEcCtD
Alitretinoin—Asthenia—Prednisone—systemic lupus erythematosus	2.39e-05	0.000132	CcSEcCtD
Alitretinoin—Pain—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000131	CcSEcCtD
Alitretinoin—Pruritus—Prednisone—systemic lupus erythematosus	2.36e-05	0.00013	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	2.34e-05	0.000271	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.33e-05	0.00027	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.31e-05	0.000269	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000126	CcSEcCtD
Alitretinoin—Diarrhoea—Prednisone—systemic lupus erythematosus	2.28e-05	0.000126	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.28e-05	0.000125	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PPARG—systemic lupus erythematosus	2.27e-05	0.000264	CbGpPWpGaD
Alitretinoin—Nausea—Dexamethasone—systemic lupus erythematosus	2.27e-05	0.000125	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—systemic lupus erythematosus	2.27e-05	0.000125	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PTGS2—systemic lupus erythematosus	2.25e-05	0.000261	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—systemic lupus erythematosus	2.25e-05	0.000261	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—systemic lupus erythematosus	2.23e-05	0.000259	CbGpPWpGaD
Alitretinoin—Urticaria—Methotrexate—systemic lupus erythematosus	2.21e-05	0.000122	CcSEcCtD
Alitretinoin—Dizziness—Prednisone—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PPARG—systemic lupus erythematosus	2.18e-05	0.000253	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	2.15e-05	0.000249	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—systemic lupus erythematosus	2.14e-05	0.000248	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—systemic lupus erythematosus	2.14e-05	0.000248	CbGpPWpGaD
Alitretinoin—Vomiting—Prednisone—systemic lupus erythematosus	2.12e-05	0.000117	CcSEcCtD
Alitretinoin—Rash—Prednisone—systemic lupus erythematosus	2.1e-05	0.000116	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—systemic lupus erythematosus	2.1e-05	0.000116	CcSEcCtD
Alitretinoin—Headache—Prednisone—systemic lupus erythematosus	2.09e-05	0.000115	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.05e-05	0.000113	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—JUNB—systemic lupus erythematosus	2.01e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	2e-05	0.000232	CbGpPWpGaD
Alitretinoin—Asthenia—Methotrexate—systemic lupus erythematosus	2e-05	0.00011	CcSEcCtD
Alitretinoin—Nausea—Prednisone—systemic lupus erythematosus	1.98e-05	0.000109	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—systemic lupus erythematosus	1.97e-05	0.000109	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.95e-05	0.000226	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TYK2—systemic lupus erythematosus	1.91e-05	0.000221	CbGpPWpGaD
Alitretinoin—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.91e-05	0.000105	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—EP300—systemic lupus erythematosus	1.87e-05	0.000217	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—EP300—systemic lupus erythematosus	1.87e-05	0.000217	CbGpPWpGaD
Alitretinoin—Dizziness—Methotrexate—systemic lupus erythematosus	1.84e-05	0.000101	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—systemic lupus erythematosus	1.77e-05	9.75e-05	CcSEcCtD
Alitretinoin—Rash—Methotrexate—systemic lupus erythematosus	1.76e-05	9.67e-05	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—systemic lupus erythematosus	1.75e-05	9.66e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.75e-05	0.000203	CbGpPWpGaD
Alitretinoin—Headache—Methotrexate—systemic lupus erythematosus	1.75e-05	9.61e-05	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.66e-05	0.000193	CbGpPWpGaD
Alitretinoin—Nausea—Methotrexate—systemic lupus erythematosus	1.65e-05	9.11e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—VDR—systemic lupus erythematosus	1.6e-05	0.000185	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.53e-05	0.000178	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—systemic lupus erythematosus	1.5e-05	0.000174	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.46e-05	0.00017	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—systemic lupus erythematosus	1.44e-05	0.000167	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EP300—systemic lupus erythematosus	1.43e-05	0.000165	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.39e-05	0.000161	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—systemic lupus erythematosus	1.35e-05	0.000157	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.28e-05	0.000149	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.27e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—systemic lupus erythematosus	1.24e-05	0.000144	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.22e-05	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.17e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—systemic lupus erythematosus	1.16e-05	0.000134	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.15e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—systemic lupus erythematosus	1.11e-05	0.000129	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.06e-05	0.000123	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	9.89e-06	0.000115	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.83e-06	0.000114	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	9.78e-06	0.000114	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—systemic lupus erythematosus	9.34e-06	0.000108	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—systemic lupus erythematosus	8.67e-06	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	7.81e-06	9.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—systemic lupus erythematosus	7.79e-06	9.04e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—systemic lupus erythematosus	7.45e-06	8.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—systemic lupus erythematosus	6.82e-06	7.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.65e-06	7.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.21e-06	7.2e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—EP300—systemic lupus erythematosus	5.67e-06	6.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.58e-06	6.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	5.48e-06	6.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.88e-06	5.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	4.38e-06	5.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.06e-06	4.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.46e-06	4.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.11e-06	3.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.98e-06	3.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.76e-06	3.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.72e-06	3.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.49e-06	2.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.38e-06	2.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.27e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.17e-06	2.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.81e-06	2.1e-05	CbGpPWpGaD
